Radiopharm Theranostics Limited
RADX
$7.03
-$0.42-5.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 720.60K | 705.70K | 450.80K | 463.60K | 98.60K |
| Total Other Revenue | 2.51M | 2.45M | 343.30K | 353.00K | -792.70K |
| Total Revenue | 3.23M | 3.16M | 794.10K | 816.60K | -694.20K |
| Cost of Revenue | 5.09M | 4.99M | 4.96M | 5.10M | 2.14M |
| Gross Profit | -1.87M | -1.83M | -4.16M | -4.28M | -2.84M |
| SG&A Expenses | 3.04M | 2.98M | 2.29M | 2.36M | 2.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.14M | 7.97M | 7.25M | 7.45M | 4.66M |
| Operating Income | -4.91M | -4.81M | -6.45M | -6.64M | -5.36M |
| Income Before Tax | -5.99M | -5.86M | -6.37M | -6.55M | -7.62M |
| Income Tax Expenses | 700.00 | 700.00 | 32.90K | 33.80K | 21.50K |
| Earnings from Continuing Operations | -5.99M | -5.87M | -6.40M | -6.58M | -7.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -293.90K | -287.80K | 299.00K | 307.40K | -358.00K |
| Net Income | -6.28M | -6.15M | -6.10M | -6.27M | -8.00M |
| EBIT | -4.91M | -4.81M | -6.45M | -6.64M | -5.36M |
| EBITDA | -4.56M | -4.47M | -5.96M | -6.13M | -4.85M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 2.33B | 2.33B | 1.84B | 1.84B | 444.60M |
| Average Diluted Shares Outstanding | 2.33B | 2.33B | 1.84B | 1.84B | 444.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |